Information Journal Paper
APA:
Copy. (2018). is it safe to switch From intravenous immunoglobulin to subcutaneous immunoglobulin in Patients With common Variable immunodeficiency and autoimmune Thrombocytopenia?. FRONTIERS IN IMMUNOLOGY, 9(-), 0-0. SID. https://sid.ir/paper/770453/en
Vancouver:
Copy. is it safe to switch From intravenous immunoglobulin to subcutaneous immunoglobulin in Patients With common Variable immunodeficiency and autoimmune Thrombocytopenia?. FRONTIERS IN IMMUNOLOGY[Internet]. 2018;9(-):0-0. Available from: https://sid.ir/paper/770453/en
IEEE:
Copy, “is it safe to switch From intravenous immunoglobulin to subcutaneous immunoglobulin in Patients With common Variable immunodeficiency and autoimmune Thrombocytopenia?,” FRONTIERS IN IMMUNOLOGY, vol. 9, no. -, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/770453/en